Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $188.02 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $43.40 | 3 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $41.58 | 2 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $35.41 | 3 | $0 (2018) |
| Abbott Laboratories | $19.82 | 1 | $0 (2018) |
| AbbVie Inc. | $19.44 | 1 | $0 (2021) |
| Allergan Inc. | $14.41 | 1 | $0 (2017) |
| Boston Scientific Corporation | $13.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $41.58 | 2 | JAZZ PHARMACEUTICALS INC. ($41.58) |
| 2021 | $19.44 | 1 | AbbVie Inc. ($19.44) |
| 2019 | $43.33 | 3 | Shire North American Group Inc ($29.37) |
| 2018 | $53.87 | 4 | Sunovion Pharmaceuticals Inc. ($20.02) |
| 2017 | $29.80 | 2 | Sunovion Pharmaceuticals Inc. ($15.39) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROLOGY | ||||||
| 02/15/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/24/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CNS | ||||||
| 08/08/2018 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/02/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: CNS | ||||||
| 11/29/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: CNS | ||||||
| 07/06/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 5,385 | 9,080 | $642,213 | $252,476 |
| 2022 | 37 | 5,207 | 8,851 | $503,057 | $238,221 |
| 2021 | 41 | 5,527 | 9,125 | $482,592 | $247,922 |
| 2020 | 38 | 5,461 | 8,613 | $454,115 | $214,852 |
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 504 | 860 | $159,100 | $66,863 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 388 | 388 | $85,360 | $48,977 | 57.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 222 | 224 | $16,740 | $16,405 | 98.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $16,240 | $15,789 | 97.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 102 | $29,376 | $12,710 | 43.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 509 | 858 | $67,294 | $11,183 | 16.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 533 | 958 | $44,068 | $9,845 | 22.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 36 | 43 | $19,737 | $9,282 | 47.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 537 | 1,076 | $15,113 | $8,999 | 59.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 525 | 956 | $29,636 | $7,218 | 24.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 39 | 441 | $19,404 | $7,123 | 36.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 232 | 234 | $8,424 | $7,055 | 83.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 332 | 558 | $31,322 | $5,281 | 16.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 33 | $10,731 | $5,099 | 47.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $5,054 | $3,071 | 60.8% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 19 | 20 | $7,360 | $2,796 | 38.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 39 | 519 | $12,975 | $2,142 | 16.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 60 | 60 | $1,800 | $1,764 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 26 | $3,120 | $1,643 | 52.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 302 | 441 | $9,799 | $1,359 | 13.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 146 | 228 | $15,504 | $1,275 | 8.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 24 | 30 | $3,300 | $1,182 | 35.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 146 | 227 | $11,804 | $1,140 | 9.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 255 | 343 | $3,698 | $749.37 | 20.3% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 47 | 47 | $2,352 | $733.20 | 31.2% |
About Dr. Scott Young, MD
Dr. Scott Young, MD is a Family Medicine healthcare provider based in Waynesboro, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144211459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Young, MD has received a total of $188.02 in payments from pharmaceutical and medical device companies, with $41.58 received in 2022. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($188.02).
As a Medicare-enrolled provider, Young has provided services to 21,580 Medicare beneficiaries, totaling 35,669 services with total Medicare billing of $953,470. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Waynesboro, VA
- Active Since 11/04/2005
- Last Updated 08/05/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1144211459
Products in Payments
- VYVANSE (Drug) $43.40
- SUNOSI (Drug) $41.58
- LATUDA (Drug) $35.41
- Proclaim Family of SCS IPGs (Device) $19.82
- HUMIRA (Biological) $19.44
- BYSTOLIC (Drug) $14.41
- GENERAL PAIN MANAGEMENT (Device) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Waynesboro
Dr. Johnny Christian, M.d, M.D
Family Medicine — Payments: $5,321
Dr. Joseph Jackson, M.d, M.D
Family Medicine — Payments: $5,031
Dr. Joseph Jackson, M.d, M.D
Family Medicine — Payments: $4,816
Dr. Michael Patti, M.d, M.D
Family Medicine — Payments: $1,938
Nizar El Kinge, M.d, M.D
Family Medicine — Payments: $1,727
Bonnie Jenkins, M.d, M.D
Family Medicine — Payments: $1,373